These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 19330229)
1. Chronic dizziness presenting in a patient with panic disorder: response to imipramine. Mezzasalma MA; Mathias Kde V; Nascimento I; Valença AM; Nardi AE Arq Neuropsiquiatr; 2009 Mar; 67(1):121-2. PubMed ID: 19330229 [No Abstract] [Full Text] [Related]
2. Imipramine on the treatment of chronic dizziness and panic disorder--3 cases report. Mezzasalma MA; Mathias Kde V; Nascimento I; Valença AM; Nardi AE Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):717-8. PubMed ID: 20307620 [No Abstract] [Full Text] [Related]
3. Imipramine for vestibular dysfunction in panic disorder: a prospective case series. Mezzasalma MA; Mathias Kde V; Nascimento I; Valença AM; Nardi AE Arq Neuropsiquiatr; 2011 Apr; 69(2A):196-201. PubMed ID: 21537560 [TBL] [Abstract][Full Text] [Related]
4. 2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia. Mavissakalian MR; Perel JM Ann Clin Psychiatry; 2001 Jun; 13(2):63-7. PubMed ID: 11534926 [TBL] [Abstract][Full Text] [Related]
5. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo. Sheikh JI; Swales PJ Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237 [TBL] [Abstract][Full Text] [Related]
6. Experimental procedures and the placebo response. Harv Ment Health Lett; 1998 Oct; 15(4):6. PubMed ID: 9755656 [No Abstract] [Full Text] [Related]
7. Lactate-induced anxiety after imipramine and diazepam treatment. Pohl R; Balon R; Berchou R; Lycaki H Anxiety; 1994; 1(2):54-63. PubMed ID: 9160549 [TBL] [Abstract][Full Text] [Related]
8. Phenomenology of panic attacks: responsiveness of individual symptoms to imipramine. Mavissakalian MR J Clin Psychopharmacol; 1996 Jun; 16(3):233-7. PubMed ID: 8784655 [TBL] [Abstract][Full Text] [Related]
10. Follow-up study of patients with panic disorder. Judd FK; Burrows GD; Norman TR Arch Gen Psychiatry; 1991 Sep; 48(9):860-2. PubMed ID: 1929779 [No Abstract] [Full Text] [Related]
11. A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapy. Marcus SM; Gorman J; Shear MK; Lewin D; Martinez J; Ray S; Goetz R; Mosovich S; Gorman L; Barlow D; Woods S Am J Psychiatry; 2007 Feb; 164(2):273-5. PubMed ID: 17267790 [TBL] [Abstract][Full Text] [Related]
12. Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. Mavissakalian MR; Perel JM Arch Gen Psychiatry; 1999 Sep; 56(9):821-7. PubMed ID: 12884888 [TBL] [Abstract][Full Text] [Related]
13. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. Barlow DH; Gorman JM; Shear MK; Woods SW JAMA; 2000 May; 283(19):2529-36. PubMed ID: 10815116 [TBL] [Abstract][Full Text] [Related]
14. Augmentation strategies with tricyclic or fluoxetine treatment in seven partially responsive panic disorder patients. Tiffon L; Coplan JD; Papp LA; Gorman JM J Clin Psychiatry; 1994 Feb; 55(2):66-9. PubMed ID: 8077156 [TBL] [Abstract][Full Text] [Related]